Andrew Seth Sandler - 17 Aug 2022 Form 4 Insider Report for ALPINE IMMUNE SCIENCES, INC.

Role
Chief Medical Officer
Signature
/s/ James Paul Rickey, attorney-in-fact
Issuer symbol
N/A
Transactions as of
17 Aug 2022
Net transactions value
$0
Form type
4
Filing time
18 Aug 2022, 17:05:11 UTC
Previous filing
08 Jul 2022
Next filing
07 Oct 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALPN Stock Option (Right to buy) Award $0 +160,000 $0.000000 160,000 17 Aug 2022 Common Stock 160,000 $8.38 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth (1/4th) of the shares subject to the option will vest on the one (1)-year anniversary of August 17, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Optionee continuing to be a Service Provider through each such date.